Eli Lilly Q2 2026 earnings beat, raises full-year revenue forecast

· finance.yahoo.com

Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates

Eli Lilly reported second-quarter revenue of $23.0 billion on Wednesday, a 48% increase from a year earlier, and lifted its full-year revenue target to a range ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI